Arcutis Biotherapeutics has a lofty goal for 2025 — and it could help Arcutis stock continue a massive run that helped shares ...

Medically reviewed by Brendan Camp, MD Hives and eczema are two of the most common skin disorders. Hives, clinically known as ...

For children with atopic dermatitis (AD), early childhood stressful life events are associated with an increased risk for disease activity, according to a study published online Jan. 28 in the Journal ...

Sales of Eylea, which the company co-developed with Bayer (DE:BAYA), rose 2% to $1.495 billion. Sales of the higher-dose, longer-lasting formulation Eylea HD rose 148% to $305 million in the U.S., ...

We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Research on the effects of olive oil for eczema is mixed. Some studies suggest it may help relieve inflammation and pain, while others found that it may damage the skin barrier and worsen symptoms.

The European Medicines Agency (EMA) currently approves dupilumab use for moderate to severe AD in patients aged 12 years and older non-responsive to conventional treatment and for AD children of 6–11 ...

The CEO discussed the success of Dupixent and the remarkable achievement of over $13 billion in global sales in 2024, highlighting its commercial advantage and setting a milestone for Sanofi.

Last September, the FDA approved Ebglyss for the treatment of eczema. With less frequent dosing, Ebglyss is expected to compete fiercely with Dupixent, a treatment that racked up over $13 billion ...

The UK's communications regulator has published guidance for website operators aimed at preventing under-18s from accessing pornographic content online via "highly effective age assurance" techniques.